<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugs_disease_country/PMC7448857/results/search/drugs/results.xml">
  <result pre="in Vero-E6 cells at noncytotoxic concentrations. The antiviral effect of" exact="gemcitabine" post="was suppressed efficiently by the cytidine nucleosides. Additionally, combination"/>
  <result pre="was suppressed efficiently by the cytidine nucleosides. Additionally, combination of" exact="gemcitabine" post="with oxysophoridine had an additive antiviral effect against SARS-CoV-2."/>
  <result pre="to cause epidemics worldwide. Different compounds, such as remdesivir and" exact="chloroquine" post="have been reported to inhibit SARS-CoV-2 replication effectively in"/>
  <result pre="lycorine and oxysophoridine against SARS-CoV-2 infection in cell culture, and" exact="chloroquine" post="was used as a positive control [1]. Vero-E6 cells"/>
  <result pre="exhibited dose-dependent inhibition of 2019-CoV replication in infected cells as" exact="chloroquine" post="(Figure 1(A)). The EC50 values of gemcitabine, lycorine, oxysophoridine"/>
  <result pre="(Figure 1(A)). The EC50 values of gemcitabine, lycorine, oxysophoridine and" exact="chloroquine" post="were 1.24, 0.31, 0.18 and 1.36 μM, respectively. To confirm"/>
  <result pre="treatment of HIV and enterovirus infection, the antiviral effect of" exact="gemcitabine" post="in combination with increased concentrations of oxysophoridine was also"/>
  <result pre="expected additive inhibitory effects were observed with the combination of" exact="gemcitabine" post="and oxysophoridine. Figure 1. The antiviral activities of gemcitabine,"/>
  <result pre="n.s. indicates no statistical differences. (E) Additive anti-SARS-CoV-2 effect of" exact="gemcitabine" post="in combination with different concentrations of oxysophoridine. The asterisks"/>
  <result pre="no statistical differences. (F) Suppression of the antiviral activity of" exact="gemcitabine" post="by cytidine. Vero-E6 cells were infected with SARS-CoV-2 and"/>
  <result pre="cells were infected with SARS-CoV-2 and simultaneously treated with 10 μM" exact="gemcitabine" post="plus different concentrations of cytidine or uridine. The asterisks"/>
  <result pre="treatment of various cancers [3]. Increasing evidence has shown that" exact="gemcitabine" post="is an effective broad spectrum antiviral agent against multiple"/>
  <result pre="of SARS-CoV-2 (1.24 μM) in our study. It is thought that" exact="gemcitabine" post="might exert its antiviral activities by targeting the salvage"/>
  <result pre="SARS-CoV-2, we added additional natural nucleosides (C and U) with" exact="gemcitabine" post="in cell culture. Similar to the previous results observed"/>
  <result pre="addition of exogenous cytidine significantly inhibited the antiviral activity of" exact="gemcitabine" post="against SARS-CoV-2 (Figure 1(F)). Our results thus indicated that"/>
  <result pre="gemcitabine against SARS-CoV-2 (Figure 1(F)). Our results thus indicated that" exact="gemcitabine" post="may inhibit SARS-CoV-2 replication through the modulation of nucleotide"/>
  <result pre="are unable to draw definitive conclusions regarding the efficacy of" exact="gemcitabine" post="against SARS-CoV-2 due to the lack of in vivo"/>
  <result pre="virus (HIV) [7]. Additionally, the mean peak plasma concentration of" exact="gemcitabine" post="observed in patients with advanced non-small cell lung cancer"/>
  <result pre="Vero-E6 cell. Altogether, these results support the therapeutic potential of" exact="gemcitabine" post="as effective antivirals with low toxicity against SARS-CoV-2. Further"/>
  <result pre="SARS-CoV-2. Further in vivo evaluation about the antiviral activity of" exact="gemcitabine" post="against SARS-CoV-2 infection is going to be carried out"/>
  <result pre="CaoR, ZhangL, YangX, LiuJ, XuM, ShiZ, HuZ, ZhongW, XiaoG.2020Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="Chemother58:4885-93. doi: 10.1128/AAC.03036-1424841273 5KuivanenS, BespalovMM, NandaniaJ, et al.Obatoclax, saliphenylhalamide and" exact="gemcitabine" post="inhibit Zika virus infection in vitro and differentially affect"/>
  <result pre="2017;139:117–128. doi: 10.1016/j.antiviral.2016.12.02228049006 6DenisovaOV, KakkolaL, FengL, et al.Obatoclax, saliphenylhalamide, and" exact="gemcitabine" post="inhibit influenza a virus infection. J Biol Chem. 2012;287:35324–32."/>
 </snippets>
</snippetsTree>
